Argon laser peripheral iridoplasty (ALPI) versus systemic intraocular pressure lowering medications as the immediate management for phacomorphic angle closure

Poster Session: Glaucoma PhenotypesPurpose: To compare the efficacy and safety of argon laser peripheral iridoplasty (ALPI) to systemic intraocular pressure (IOP) lowering medications in the immediate management of phacomorphic angle closure. Patients and methods: This was a prospective randomized controlled study conducted at a district hospital in Hong Kong, China. Consecutive cases of phacomorphic angle closure were recruited from December 2009 to December 2010. Patients received intravenous (IV) and oral carbonic anhydrase inhibitor or ALPI as the initial treatment. IV mannitol was administered in both groups for presenting IOP > 60 mmHg or IOP > 40 mmHg 2 hours post treatment. The following perimeters were compared between the 2 arms: Snellen best correct visual acuity (BCVA); duration of symptoms; presenting IOP; IOP at 15 minutes, 30minutes and hourly after treatment until IOP < 25 mmHg; post-op angle, retinal nerve fibre layer (RNFL), endothelial count, BCVA and IOP. Results: Ten consecutive cases were included in the study. Six cases received medication therapy and 4 received ALPI. The mean age was 79.7 ± 7.2 in the medical therapy group and 78.3 ± 11.0 in the ALPI group. The presenting IOP was 50.7 ± 8.4 mmHg and 50.25 ± 6.9 mmHg in the medical therapy and ALPI group respectively. The duration of phacomorphic glaucoma in the medical group was 2.8 ± 3.5 days and 0.9 ± 0.25 days in the ALPI group. In the medical therapy group, 50% (3/6) required IV mannitol and none in the ALPI group. The time taken to reduce the presenting IOP to < 25 mmHg was 115.0 ± 97.0 minutes in the medical therapy group and 18.8 ± 7.5 minutes in the ALPI group. Within the first 30minutes, the drop in IOP was 20.8 ± 13.5mmHg in the medical group and 34.8 ± 3.2mmHg in the ALPI group, representing a 41.0% and 69.3% drop in IOP respectively. The degree of peripheral anterior synechiae (PAS) formation at 3 months was 45 ± 45.3° and 22.5 ± 5° in the medical and ALPI group respectively. The RNFL, angle, endothelial count, post-op VA and IOP were comparable in both groups. Conclusion: ALPI is an effective and safe IOP lowering modality in acute phacomorphic angle closure, offering a more rapid reduction of IOP, avoiding the use of systemic carbonic anhydrase inhibitor and hyperosmotic agents, and with seemingly less PAS formation and comparable post-op results as compared to medical therapy. ALPI should replace medical therapy as first line treatment in phacomorphic angle closure especially in elderly patients cannot tolerable the side effects of systemic IOP-lowering medication.published_or_final_versio

Cost-Precision Tradeoffs in 3D Air Pollution Mapping using WSN

Best Paper AwardInternational audienceAir pollution has become a major issue of modern megalopo-lis, where the majority of world population lives. Measuring air pollution levels is an important step in designing and assessing air quality related public policies. Unfortunately, existing solutions are inadequate to get insights on the real exposition of citizens. In particular, high quality sensors deployed today are too large and too costly to envision a three dimensional deployment at the scale of a street. In this paper, we investigate the deployment of wireless sensor networks (WSN) used for building a three-dimensional mapping of pollution concentrations. We consider in our simulations a 3D model of air pollution dispersion based on real experiments performed in wind tunnels emulating the pollution emitted by a steady state traffic flow in a typical street canyon. Our contribution is to analyze the performances of different 3D WSN topologies in terms of the trade-off between the economical cost of the infrastructure and the quality of the reconstructed air pollution mapping

Validating the model of predictors of academic self-handicapping behavior

The main aim of the present study is to validate the model of predictors of self-handicapping behavior (POASH) on the data derived from undergraduate students in an ongoing co-curriculum compulsory course. The study adapted and extended the original theory of reciprocal interaction of emotion, cognition and behavior by adding self-handicapping behavior component. In so doing, this study assessed the direct and indirect effects of emotion, cognition and behavior via student engagement on self-handicapping behavior. The second purpose of the study is to evaluate gender and nationality status invariants of the causal structure of POASH. This cross-validation procedure determined whether gender and nationality status moderated the causal structure of the model, and thus the generality of POASH. The data was collected from two self-reported questionnaires administered to 790 undergraduates of an International Islamic University in Malaysia. A confirmatory three-step approach theory testing and development using Maximum Likelihood method was applied. The results of structured equation modeling supported the adequacy of POASH and the causal structure of POASH proved to be applicable to both genders and nationality statuses

A Range of Earth Observation Techniques for Assessing Plant Diversity

AbstractVegetation diversity and health is multidimensional and only partially understood due to its complexity. So far there is no single monitoring approach that can sufficiently assess and predict vegetation health and resilience. To gain a better understanding of the different remote sensing (RS) approaches that are available, this chapter reviews the range of Earth observation (EO) platforms, sensors, and techniques for assessing vegetation diversity. Platforms include close-range EO platforms, spectral laboratories, plant phenomics facilities, ecotrons, wireless sensor networks (WSNs), towers, air- and spaceborne EO platforms, and unmanned aerial systems (UAS). Sensors include spectrometers, optical imaging systems, Light Detection and Ranging (LiDAR), and radar. Applications and approaches to vegetation diversity modeling and mapping with air- and spaceborne EO data are also presented. The chapter concludes with recommendations for the future direction of monitoring vegetation diversity using RS

To compare the efficacy and safety of argon laser peripheral iridoplasty (ALPI) to systemic intraocular pressure (IOP) lowering medications in the immediate management of acute phacomorphic angle closure

Glaucoma free paper session 3BACKGROUND: The purpose of this study was to compare the efficacy and safety of argon laser peripheral iridoplasty (ALPI) and systemic intraocular pressure (IOP)-lowering medications in the immediate management of acute phacomorphic angle closure. METHODS: Consecutive cases of acute phacomorphic angle closure were randomized to receive ALPI and an intravenous or oral carbonic anhydrase inhibitor as initial treatment. Intravenous mannitol was administered for presenting IOP > 60 mmHg or IOP > 40 mmHg 2 hours posttreatment in both arms. RESULTS: Of 10 consecutive cases, six received medical therapy and four received ALPI. Fifty percent in the medical group and none in the ALPI group required intravenous mannitol. The ALPI group took less time to achieve IOP < 25 mmHg (18.8 ± 7.5 minutes versus 115.0 ± 97.0 minutes, P = 0.001, F test); had a greater IOP reduction within 30 minutes (69.8% ± 7.7% versus 40.9 ± 23.9%, P = 0.03, t-test); and had a consistently smaller post-attack cup to disc ratio (0.50 ± 0.02 versus 0.60 ± 0.20, P = 0.002, F test). CONCLUSION: ALPI offers greater safety, consistency, and efficacy than systemic IOP-lowering medications as initial treatment for phacomorphic angle closure

Argon laser peripheral iridoplasty versus systemic intraocular pressure-lowering medications as immediate management for acute phacomorphic angle closure

Jacky WY Lee,1 Jimmy SM Lai,1 Doris WF Yick,2 Can YF Yuen21Department of Ophthalmology, University of Hong Kong, 2Department of Ophthalmology, The Caritas Medical Centre, Kowloon West Cluster, Hong Kong, People&amp;rsquo;s Republic of ChinaBackground: The purpose of this study was to compare the efficacy and safety of argon laser peripheral iridoplasty (ALPI) and systemic intraocular pressure (IOP)-lowering medications in the immediate management of acute phacomorphic angle closure.Methods: Consecutive cases of acute phacomorphic angle closure were randomized to receive ALPI and an intravenous or oral carbonic anhydrase inhibitor as initial treatment. Intravenous mannitol was administered for presenting IOP &amp;gt; 60 mmHg or IOP &amp;gt; 40 mmHg 2 hours posttreatment in both arms.Results: Of 10 consecutive cases, six received medical therapy and four received ALPI. Fifty percent in the medical group and none in the ALPI group required intravenous mannitol. The ALPI group took less time to achieve IOP &amp;lt; 25 mmHg (18.8 &amp;plusmn; 7.5 minutes versus 115.0 &amp;plusmn; 97.0 minutes, P = 0.001, F test); had a greater IOP reduction within 30 minutes (69.8% &amp;plusmn; 7.7% versus 40.9 &amp;plusmn; 23.9%, P = 0.03, t-test); and had a consistently smaller post-attack cup to disc ratio (0.50 &amp;plusmn; 0.02 versus 0.60 &amp;plusmn; 0.20, P = 0.002, F test).Conclusion: ALPI offers greater safety, consistency, and efficacy than systemic IOP-lowering medications as initial treatment for phacomorphic angle closure.Keywords: phacomorphic, glaucoma, argon laser peripheral iridoplasty, medical, intraocular pressur

Argon Laser Peripheral Iridoplasty versus Systemic Intraocular Pressure Lowering Medications as the Immediate Management for Acute Phacomorphic Angle Closure

BACKGROUND: The purpose of this study was to compare the efficacy and safety of argon laser peripheral iridoplasty (ALPI) and systemic intraocular pressure (IOP)-lowering medications in the immediate management of acute phacomorphic angle closure. METHODS: Consecutive cases of acute phacomorphic angle closure were randomized to receive ALPI and an intravenous or oral carbonic anhydrase inhibitor as initial treatment. Intravenous mannitol was administered for presenting IOP > 60 mmHg or IOP > 40 mmHg 2 hours posttreatment in both arms. RESULTS: Of 10 consecutive cases, six received medical therapy and four received ALPI. Fifty percent in the medical group and none in the ALPI group required intravenous mannitol. The ALPI group took less time to achieve IOP < 25 mmHg (18.8 ± 7.5 minutes versus 115.0 ± 97.0 minutes, P = 0.001, F test); had a greater IOP reduction within 30 minutes (69.8% ± 7.7% versus 40.9 ± 23.9%, P = 0.03, t-test); and had a consistently smaller post-attack cup to disc ratio (0.50 ± 0.02 versus 0.60 ± 0.20, P = 0.002, F test). CONCLUSION: ALPI offers greater safety, consistency, and efficacy than systemic IOP-lowering medications as initial treatment for phacomorphic angle closure

Assessment of glaucomatous optic neuropathy in phacomorphic angle closure

To investigate the retinal nerve fibre layer (RNFL) changes after an acute attack of phacomorphic angle closure. This prospective study involved ten cases of phacomorphic angle closure that underwent cataract extraction and intraocular lens insertion after intraocular pressure lowering. Apart from visual acuity and intraocular pressure (IOP), RNFL thickness and vertical cup disc ratio (VCDR) were measured by optical coherence tomography (OCT) at 3-9 months post attack. Humphrey visual field assessment was performed at 9 months post attack. All cases had mean phacomorphic duration of 0.2. Patients with <5 days duration of phacomorphic angle closure are likely to have reasonable postoperative vision. An acute episode of phacomorphic angle closure can trigger an accelerated RNFL thinning despite normal IOP and open angles, most noticeable in the superior and inferior quadrants, occurring between 3 and 9 months post attack. Glaucomatous optic neuropathy in the attack eye was evident by OCT but not by visual field assessment at the same time interval

Primary acute angle closure: a 10-year visual, pressure, and treatment trend in Hong Kong Chinese

To investigate long-term clinical outcomes after acute angle closure in the Chinese population. A 10-year retrospective review of primary acute angle closure in Hong Kong Chinese to document patient demographics, treatment, and pre- and post-acute angle closure intraocular pressure (IOP) and visual acuity (VA). The year of attack was correlated with the timing of laser, last VA and IOP, and the number of anti-glaucoma eye drops. In 210 eyes (200 patients), 10 % had a simultaneous bilateral acute angle closure. VA improvement was noted in 68.6 % of eyes whilst 11.4 % were blinded. At 3.7 ± 2.4 years of follow-up, 49.5 % had IOP <21 mmHg with medication or surgery, 41.9 % needed anti-glaucoma eye drops, and 13.8 % had undergone trabeculectomy. The older the year of attack, the poorer the VA (r = 0.2, p = 0.03) and the longer the laser wait time (r = 0.3, p < 0.0001). VA outcome and laser promptness in acute angle closure has improved over the years. At 4 years after the attack, 50 % had normal IOP, 69 % had improved VA but 11 % were blinded